Survival Outcomes in EGFR‐Mutant Non‐Small Cell Lung Cancer With Brain Metastases: Kaplan–Meier and Cox Regression Analyses Across Treatment Stages
ABSTRACT Background Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have shown significant efficacy in patients with brain metastases (BMs) from EGFR‐mutated non‐small cell lung cancer (NSCLC). However, acquired resistance is inevitable, and clinical data addressing key quest...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | The Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/crj.70085 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|